Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention.
Xiaoling XuMingfeng HanTiantian LiWei SunDongsheng WangBinqing FuYonggang ZhouXiaohu ZhengYun YangXiuyong LiXiaohua ZhangAijun PanHaiming WeiPublished in: Proceedings of the National Academy of Sciences of the United States of America (2020)